Skip to content
★ Sign in to follow
Alumis Inc. logo

Alumis Inc. Stock: price and insider trades · United States

US·Mcap US$793.4MHealth Care

1 insider bought €7.1M of shares over the last 90 days, the latest by AKKARAJU SRINIVAS, filed 09 Sept 2026.

Insider Decl.
174
Thresholds
n/a
Buy Volume
€95M
36 ops. · all time
Sell Volume
€1M
15 ops. · all time

Alumis Inc.: what insiders have been doing

Alumis Inc. belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). In the past year (14 November 2025 to 14 November 2026), 61 filings came from 15 insiders.

Both sides are active: 25 purchases worth €32.6M and 15 sales worth €1.4M, from 3 insiders and 7 insiders respectively. The net balance comes to €31.3M on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €8.6M, bought by Akkaraju Srinivas and made public on 13 January 2026. The buyers include 2 major shareholders and 1 senior executive.

For context, the typical company on the same exchange (median of 3,183 companies) published 24 filings over the same period, against 61 filings here. Since 2024, the database holds 36 purchases and 15 sales by insiders of the company. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 24.1 m USD and net income of -243.3 m USD.

In all, 21 purchases were made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The most recent open-market purchase was published on 9 September 2026, 69 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Drägerwerk AG & Co. KGaA. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Who traded when

BuySale
Srinivas Akkaraju21 buys2 sales
Foresite Capital Management VI LLC5 buys
Foresite Labs, LLC3 buys
Sanam Pangali3 sales
Colowick Alan2 buys
David M. Goldstein2 sales

+6 other insiders

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$6.13
Analyst consensus
8 analysts
1.30/5
US$15.00Target US$31.13(+408%)US$46.00
Income statement
RevenueUS$24.1M
EBITDA-US$450.3M-1872% margin
Net income-US$243.3M-1011.7% margin
Valuation
PER (forward)-2.1x
P/Book1.7x
Beta-0.27
Balance sheet & cash
Market capUS$793.4M
Total debtUS$36.9M
Free Cash Flow-US$370.2M
Debt / Equity8%
Profitability & ownership
ROE-93.6%
ROA-45.3%
% insiders0.5%
% institutions88.3%
Last declaration on 4 November 2026

T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.

Declarations174 total
  • ▼
    Chief Medical OfficerExecutives
    3,866 USD31SEC
    593 shares@ US$6.520.0005% mcap1.6% of flowCommon StockSEC:0001789317-26-000009:0
  • ▼
    Chief Development OfficerExecutives
    4,062 USD32SEC
    623 shares@ US$6.520.0005% mcap5.8% of flowCommon StockSEC:0002023657-26-000007:0
  • ▼
    Chief Financial OfficerExecutives
    5,177 USD46SEC
    794 shares@ US$6.520.0006% mcap5.8% of flowCommon StockSEC:0001744578-26-000007:0
  • ▼
    Chief Legal OfficerExecutives
    2,165 USD37SEC
    332 shares@ US$6.520.0003% mcap1.1% of flowCommon StockSEC:0002023806-26-000009:0
  • ▼
    Chief Business & Strategy OfcrExecutives
    4,251 USD38SEC
    652 shares@ US$6.520.0005% mcap5.8% of flowCommon StockSEC:0001506218-26-000007:0
  • ▼
    Chief Scientific OfficerExecutives
    4,101 USD38SEC
    629 shares@ US$6.520.0005% mcap5.8% of flowCommon StockSEC:0001751719-26-000010:0
  • ▲
    DirectorExecutives
    2M USD31SEC
    220,070 shares@ US$11.1730.29% mcap4.3% of flowCommon StockSEC:0001231919-26-001158:0
    Canonical exit: 3 Dec 2026 (T+90)
  • ▼
    DirectorExecutives
    507,019 USD27SEC
    48,066 shares@ US$10.54840.060% mcap0.9% of flowCommon StockSEC:0001231919-26-001158:2
  • ▼
    DirectorExecutives
    507,009 USD27SEC
    48,065 shares@ US$10.54840.060% mcap0.9% of flowCommon StockSEC:0001231919-26-001158:3
  • ▲
    DirectorExecutives
    3M USD32SEC
    273,291 shares@ US$10.62710.34% mcap5.1% of flowCommon StockSEC:0001231919-26-001158:4
    Canonical exit: 7 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    3M USD32SEC
    273,290 shares@ US$10.62710.34% mcap5.1% of flowCommon StockSEC:0001231919-26-001158:5
    Canonical exit: 7 Dec 2026 (T+90)
  • ▼
    Chief Business & Strategy OfcrExecutives
    70,988 USD37SEC
    2,692 shares@ US$26.370.0074% mcap94.2% of flowCommon StockSEC:0001506218-26-000005:0
  • ▼
    Chief Financial OfficerExecutives
    86,546 USD45SEC
    3,282 shares@ US$26.370.0090% mcap94.2% of flowCommon StockSEC:0001744578-26-000005:0
  • ▼
    Chief Scientific OfficerExecutives
    68,457 USD37SEC
    2,596 shares@ US$26.370.0072% mcap94.2% of flowCommon StockSEC:0001751719-26-000008:0
  • ▼
    Chief Medical OfficerExecutives
    64,527 USD32SEC
    2,447 shares@ US$26.370.0067% mcap26.2% of flowCommon StockSEC:0001789317-26-000007:0
  • ▼
    Chief Development OfficerExecutives
    67,824 USD37SEC
    2,572 shares@ US$26.370.0071% mcap94.2% of flowCommon StockSEC:0002023657-26-000005:0
  • ▼
    Chief Legal OfficerExecutives
    35,969 USD31SEC
    1,364 shares@ US$26.370.0038% mcap17.6% of flowCommon StockSEC:0002023806-26-000007:0
  • ◇
    Chief Legal OfficerExecutives
    25,300 USD12SEC
    5,000 shares@ US$5.060.0027% mcap12.5% of flowCommon StockSEC:0002023806-26-000005:0
  • ▼
    Chief Legal OfficerExecutives
    140,000 USD18SEC
    5,000 shares@ US$28.000.015% mcap68.9% of flowCommon StockSEC:0002023806-26-000005:1
  • ●
    OfficerExecutives
    140,000 USD26Source
    5,000 shares@ US$28.000.015% mcap100.0% of flowCommonSEC144:0001950047-26-006850
  • ◆
    DirectorExecutives
    0SEC
    3,553 sharesCommon StockSEC:0001253170-26-000011:0
  • ◆
    DirectorExecutives
    0SEC
    3,553 sharesCommon StockSEC:0001311210-26-000006:0
  • ◆
    DirectorExecutives
    0SEC
    3,553 sharesCommon StockSEC:0001326228-26-000004:0
  • ◆
    DirectorExecutives
    0SEC
    3,553 sharesCommon StockSEC:0001569226-26-000005:0
  • ◆
    DirectorExecutives
    0SEC
    3,553 sharesCommon StockSEC:0001645512-26-000003:0

25 of 174 declarations

About Alumis Inc.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations

The weekly insider digest, free

One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.